drugset / Trial / NCT07592572

A Study of the Effects of Itraconazole on LY4395089 in Healthy Participants

NCT07592572

Phase 1 Recruiting 14 enrolled Eli Lilly and Company
Non-randomizedSequentialOpen-labelBasic science

Summary

The purpose of the study is to see how itraconazole affects LY4395089 in healthy participants. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. There will be fifteen inpatient stays at the clinical research unit (CRU). The study will last about 2 weeks.

Timeline

Start
2026-05-20
Primary completion
2026-07
Completion
2026-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule Oral
Subject LY4395089 Unknown Oral

Indications

No indication recorded.